A Changing Landscape: How Pandemic Response Affects Antimicrobial Resistance
Media Inquiries
For any questions about the event or how we can help, reach out to our FHI 360 media contact.
Join FHI 360 for a two-day virtual symposium with global experts in infectious diseases and global health security to discuss the emerging consequences of the intersection between the COVID-19 pandemic and antimicrobial resistance (AMR).
AMR is a global public health threat with a substantial human and economic impact. It occurs when bacteria, fungi and parasites stop responding to and become resistant to antimicrobial medications. The scale of AMR has increased rapidly in recent years, especially in countries where regulations that control antibiotic prescription and use in humans and animals are weak or nonexistent.
The COVID-19 pandemic may have long-term consequences on the continued global emergence and acceleration of AMR, and researchers are exploring how antibiotic use changed during this time. Countries and health systems need to act now to address this public health threat.
This symposium, hosted by FHI 360's Emerging Infectious Diseases and Health Security Division, will provide thought leadership on how increased and inappropriate use of antibiotics during a pandemic can lead to undesirable consequences.
Sessions will address these topics:
| 8:30am ET |
Opening PlenaryWelcomeJanet Robinson, FIBS, Director, Emerging Infectious Diseases and Health Security, FHI 360 Keynote Address Lord Jim O’Neill, Economist and Chairman, Council of Chatham House, the Royal Institute of International Affairs |
|---|---|
| 8:50am ET |
Panel Discussion and Q&AModeratorPat Sadate-Ngatchou, PhD, Technical Director, Emerging Infectious Diseases and Health Security, FHI 360 Panelists Bradley Langford, BscPhm, ACPR, PharmD, BCPS, Pharmacist Consultant, Antimicrobial Stewardship Program, Public Health Ontario Thuy Doan, MD, PhD, Associate Professor, Proctor Foundation, University of California at San Francisco Sabiha Essack, BPharm, MPharm, PhD, South African Research Chair in Antibiotic Resistance and One Health and Professor in Pharmaceutical Sciences, University of KwaZulu-Natal Isidore Bonkoungou, PhD, Assistant Professor in Microbiology, University Joseph KI-ZERBO (University of Ouagadougou) |
| 9:30am ET |
Breakout Session #1Lessons learned from antibiotic use and misuse during the COVID-19 pandemicModerator and rapporteur: Bradley Langford Role and importance of laboratory diagnostics in mitigating the impact of AMR Moderator and rapporteur: Thuy Doan The importance of integrating AMR stewardship measures into the pandemic response in countries Moderator and rapporteur: Sabiha Essack One Health: Zoonoses implications for AMR Moderator and rapporteur: Isidore Bonkoungou |
| 10:00am ET |
Closing Remarks for Day 1Janet Robinson |
| 8:30am ET |
Opening PlenaryWelcomeJanet Robinson |
|---|---|
| 8:35am ET |
Breakout Session #2Summary Reports from Breakout Session #1 and Presentation of Solution FrameworkLessons learned from antibiotic use and misuse during the COVID-19 pandemic Bradley Langford Role and importance of laboratory diagnostics in mitigating the impact of AMR Thuy Doan The importance of integrating AMR stewardship measures into the pandemic response in countries Sabiha Essack One Health: Zoonoses implications for AMR Isidore Bonkoungou |
| 10:00am ET |
Closing PlenarySummary, Lessons Learned, Blog Launch and Closing RemarksJanet Robinson |
FHI 360
@FHI 360